Bausch Health Co. Inc. (BHC) Announces Resubmission of U.S. NDA Application for DUOBRII (halobetasol propionate and tazarotene) Lotion
Tweet Send to a Friend
Ortho Dermatologics, a division of Bausch Health Companies Inc. (NYSE: BHC), today announced it has resubmitted a New Drug Application ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
